News

Hosted on MSN8mon
FDA moves the needle, approves first nasal spray for treatment of severe allergic reactions
On Friday, the FDA announced the approval of neffy, an epinephrine nasal spray by ARS Pharmaceuticals ... The decision helps patients move away from the needle most commonly used in the brand ...
Prevention16d
SinuCleanse Nasal Wash Recall Updated to ‘Deadly’ Risk by FDA—Here’s Why
The U.S. Food and Drug Administration classified a recent nasal wash recall for SinuCleanse. The recall, initiated due to microbial contamination, has been officially labeled a Class 1 recall ...
Nasdaq1mon
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg, First Needle-Free Epinephrine Treatment for Children Ages 4 and Up
neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...
AOL16d
FDA: Nasal Wash Recall Updated to ‘Deadly’ Risk—Here’s What to Know
The U.S. Food and Drug Administration classified a recent nasal wash recall for SinuCleanse. The recall, initiated due to microbial contamination, has been officially labeled a Class 1 recall ...